The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Four in 10 patients treated with chemotherapy experience persistent severe peripheral nerve pain, a recent study found. The study, published in Regional Anesthesia & Pain Medicine, analyzed data ...

San Antonio teamed up with Angeles Sin Fronteras to provide free wigs and cosmetic kits to local cancer patients undergoing ...

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term ...

Patients with stage IA HER2+ breast cancer and smaller tumors had high BCSS rates whether they received adjuvant chemotherapy or not.

Managing maximum tolerated dose (MTD) chemotherapy while minimizing neutropenia relies on precise complete blood count (CBC) monitoring and AI-powered diagnostics.

Dr. Julia Compton looks over scans at Hancock Regional Hospital. Construction will soon start to double the number of chairs at Sue Ann Wortman Cancer Center’s infusion center. GREENFIELD ...

Patients treated with platinum-based agents ... of chronic painful neuropathy is 41.2% among individuals with chemotherapy-induced peripheral neuropathy (CIPN), according to a meta-analysis ...